Gene · 3003
Papers2,892
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
461 to 480 of 2,892
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Widespread and dynamic expression of granzyme C by skin-resident antiviral T cells. | Front Immunol | 2023 | 37809077 | PubTator, text mining | PubMed |
| Neoantigen-specific CD4+ tumor-infiltrating lymphocytes are potent effectors identified within adoptive cell therapy products for metastatic melanoma patients. | J Immunother Cancer | 2023 | 37802604 | PubTator, text mining | PubMed |
| MCProj: metacell projection for interpretable and quantitative use of transcriptional atlases. | Genome Biol | 2023 | 37798781 | PubTator, text mining | PubMed |
| Single-cell analysis reveals altered tumor microenvironments of relapse- and remission-associated pediatric acute myeloid leukemia. | Nat Commun | 2023 | 37798266 | PubTator, text mining | PubMed |
| Comprehensive immunophenotyping of solid tumor-infiltrating immune cells reveals the expression characteristics of LAG-3 and its ligands. | Front Immunol | 2023 | 37795090 | PubTator, text mining | PubMed |
Interactions of Indoleamine 2,3-dioxygenase-expressing LAMP3+ dendritic cells with CD4+ regulatory T cells and CD8+ exhausted T cells: synergistically remodeling of the immunosuppressive microenvironment in cervical cancer and therapeutic implications. | Cancer Commun (Lond) | 2023 | 37794698 | PubTator, text mining | PubMed |
| Chronic alcohol consumption dysregulates innate immune response to SARS-CoV-2 in the lung. | EBioMedicine | 2023 | 37793211 | PubTator, text mining | PubMed |
| Single-cell transcriptomic analysis of gingivo-buccal oral cancer reveals two dominant cellular programs. | Cancer Sci | 2023 | 37792582 | PubTator, text mining | PubMed |
| Immune Responses in Checkpoint Myocarditis Across Heart, Blood, and Tumor. | bioRxiv | 2023 | 37790460 | PubTator, text mining | PubMed |
| Peripheral Blood Single-Cell Sequencing Uncovers Common and Specific Immune Aberrations in Fibrotic Lung Diseases. | bioRxiv | 2023 | 37786685 | PubTator, text mining | PubMed |
| Unravelling the role of immune cells and FN1 in the recurrence and therapeutic process of skull base chordoma. | Clin Transl Med | 2023 | 37784253 | PubTator, text mining | PubMed |
| Pro-tumor Tfh2 cells induce detrimental IgG4 production and PGE2-dependent IgE inhibition in pancreatic cancer. | EBioMedicine | 2023 | 37776595 | PubTator, text mining | PubMed |
| Highly multiplexed spatial analysis identifies tissue-resident memory T cells as drivers of ulcerative and immune checkpoint inhibitor colitis. | iScience | 2023 | 37766980 | PubTator, text mining | PubMed |
| CircSOBP suppresses the progression of glioma by disrupting glycolysis and promoting the MDA5-mediated immune response. | iScience | 2023 | 37766977 | PubTator, text mining | PubMed |
| Investigating the Heterogeneity of Immune Cells in Triple-Negative Breast Cancer at the Single-Cell Level before and after Paclitaxel Chemotherapy. | Int J Mol Sci | 2023 | 37762493 | PubTator, text mining | PubMed |
| Single-Cell RNA-Sequencing Reveals Peripheral T Helper Cells Promoting the Development of IgG4-Related Disease by Enhancing B Cell Activation and Differentiation. | Int J Mol Sci | 2023 | 37762039 | PubTator, text mining | PubMed |
| Immune Checkpoint Inhibitors Targeting the PD-1/PD-L1 Pathway in Advanced, Recurrent Endometrial Cancer: A Scoping Review with SWOT Analysis. | Cancers (Basel) | 2023 | 37760602 | PubTator, text mining | PubMed |
| Identifying New Contributors to Brain Metastasis in Lung Adenocarcinoma: A Transcriptomic Meta-Analysis. | Cancers (Basel) | 2023 | 37760494 | PubTator, text mining | PubMed |
| A New Understanding of Long Non-Coding RNA in Hepatocellular Carcinoma-From m6A Modification to Blood Biomarkers. | Cells | 2023 | 37759495 | PubTator, text mining | PubMed |
| Newborn and child-like molecular signatures in older adults stem from TCR shifts across human lifespan. | Nat Immunol | 2023 | 37749325 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3003/papers?page=24